PharmaVentures Appoints Paul Phull as Senior Director

New Business Development Expert Brings More Than 20 Years of Industry M&A and Licensing Experience to Strengthen Pharmaventures' Corporate Advisory Services to its Clients

OXFORD, England, August 31, 2010 - PharmaVentures Ltd (www.pharmaventures.com) ("PharmaVentures")
today announced that Paul Phull has joined the company as Senior Director.
With more than 24 years of senior level commercial, business/corporate
development and general management experience in the pharmaceutical,
biotechnology and medical device industries, Paul will be responsible for
developing PharmaVentures' Corporate Advisory business.

Paul joins PharmaVentures from Sinclair Pharma plc, a UK listed specialty
pharmaceutical company, where he was responsible for the development of the
international business with a marketing partner network spanning over 80
countries. He was also responsible for corporate development and worked on
the acquisition and integration of European sales and marketing companies in
France, Spain and Italy into the Sinclair group. Paul has significant deal
making and corporate transaction experience with a broad range and size of
companies in Europe, USA, Japan, India and Asia in a number of therapeutic
areas.

"I am very pleased to welcome Paul to PharmaVentures," said Dr Fintan
Walton, Chief Executive Officer. "His strategic approach and industry
experience will significantly enhance corporate advisory services,
particularly with respect to our transactions offerings."

About PharmaVentures

PharmaVentures Limited (www.pharmaventures.com) is based in
Oxford, England and is a leading international corporate advisory firm
supporting its clients' growth ambitions through licensing, joint ventures
and M&A in the healthcare industry. The company works for a variety of
clients from start-ups to global pharmaceutical corporations, their advisors,
investment companies and government bodies. It also produces the highly
popular PharmaDeals(R) range of intelligence products including analysis
tools and reports. In 2006 it launched the world's first dedicated online
pharmaceutical television channel PharmaTelevision(R) (
www.pharmatelevision.com)

    Doug Cookson
    Commercial Director,
    PharmaVentures
    T: +44(0)1865-332731
    E: doug.cookson@pharmaventures.com

Doug Cookson, Commercial Director, PharmaVentures, T: +44(0)1865-332731, E: doug.cookson at pharmaventures.com